News
Telemedicine reduces cardiovascular mortality in chronic heart failure by up to 54%
The combination of telemonitoring and teleintervention reduces episodes of decompensation by 70% and cardiovascular mortality by 54% in people with chronic heart failure.
Rediscovering denosumab: from osteoporosis treatment to a possible role against breast cancer
The first results of a clinical trial have emerged that reveal the potential for denosumab, an osteoporosis drug, to be used in breast cancer.
The first device capable of activating a light-activated drug by remote control has been designed
A wireless device capable of remotely activating a photopharmaceutical with proven therapeutic effect has been designed
A new combined strategy to overcome immune resistance in metastatic uveal melanoma
The combination of tebentafusp and IL-2 could benefit metastatic uveal melanoma patients.
Honorary Diploma of the Catalan Society of Psychiatry and Mental Health for Dr. Jiménez-Murcia and Dr. Fernández-Aranda
The Catalan Society of Psychiatry and Mental Health has recognized the contribution of both professionals, national and international leaders in clinical psychology
New oral drug shows high efficacy in HER2-mutated lung cancer
Zongertinib could become a new tool in the treatment of HER-2 mutated lung cancer, specially for an specific group of patients
New study on the causes of severe COVID-19 in vaccinated patients
A type of autoantibodies is demonstrated to be an independent risk factor for the severity of COVID-19
Kleptomania: Bellvitge leads a new approach in the study and treatment of the disease
Kleptomania is described for the first time not only as an impulsive disorder, but also as a compulsive disorder.
Two new gene-editing tools have been created from microorganisms of the bottom of the ocean: Asterix and Obelix’s CRISPR
The new tools are highly efficient, operate at colder temperatures, and appear to be more specific than the canonical system.